Healthcare AI Leader Parminder Bhatia Joins Helio Genomics Board of Directors
IRVINE, Calif., July 16, 2026 /PRNewswire/ -- Helio Genomics, Inc., a commercial-stage AI-powered precision liver diagnostics company focused on improving outcomes for at-risk patients through early cancer detection, disease surveillance, and biomarker-driven precision medicine, today...
IRVINE, Calif., July 16, 2026 /PRNewswire/ -- Helio Genomics, Inc., a commercial-stage AI-powered precision liver diagnostics company focused on improving outcomes for at-risk patients through early cancer detection, disease surveillance, and biomarker-driven precision medicine, today...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.